Interferon-β treatment in patients with childhood-onset multiple sclerosis

We present a report of the use of interferon-β before 18 years of age in 16 patients with childhood-onset multiple sclerosis. This study demonstrated that the treatment is safe and well tolerated. (J Pediatr 2001;139:443-6)

Saved in:
Bibliographic Details
Published in:The Journal of pediatrics 2001-09, Vol.139 (3), p.443-446
Main Authors: Mikaeloff, Yann, Moreau, Thibault, Debouverie, Marc, Pelletier, Jean, Lebrun, Christine, Gout, Olivier, Pedespan, Jean-Michel, Van Hulle, Catherine, Vermersch, Patrick, Ponsot, Gérard
Format: Article
Language:English
Subjects:
Adjuvants, Immunologic - adverse effects
Adjuvants, Immunologic - therapeutic use
Adolescent
Biological and medical sciences
Child
Female
Humans
Interferon-beta - adverse effects
Interferon-beta - therapeutic use
Male
Medical sciences
Miscellaneous
Multiple Sclerosis - drug therapy
Neuropharmacology
Pharmacology. Drug treatments
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We present a report of the use of interferon-β before 18 years of age in 16 patients with childhood-onset multiple sclerosis. This study demonstrated that the treatment is safe and well tolerated. (J Pediatr 2001;139:443-6)
ISSN:0022-3476
1097-6833
DOI:10.1067/mpd.2001.117004